CRNO B — Cereno Scientific AB Balance Sheet
0.000.00%
- SEK2.25bn
- SEK2.32bn
Annual balance sheet for Cereno Scientific AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | Interim Report | ARS | ARS | PRESS |
Standards: | SAS | SAS | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 66 | 89.6 | 67 | 87.2 | 128 |
Net Total Receivables | 0.84 | 1.4 | 1.25 | 1.12 | 2.88 |
Prepaid Expenses | |||||
Total Current Assets | 67.5 | 91.2 | 68.6 | 88.7 | 133 |
Net Property, Plant And Equipment | 0.057 | 0.043 | 0.029 | 0.014 | 3.6 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 112 | 181 | 216 | 285 | 414 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 12.1 | 10.3 | 13.7 | 23.2 | 31.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 12.5 | 10.7 | 14.1 | 68.6 | 222 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 99.7 | 170 | 202 | 216 | 192 |
Total Liabilities & Shareholders' Equity | 112 | 181 | 216 | 285 | 414 |
Total Common Shares Outstanding |